Tsingke Biotech Overview
- Year Founded
-
2017
- Status
-
IPO Registration
- Employees
-
1,252
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
14
Tsingke Biotech General Information
Description
Developer and manufacturer of gene synthesis and sequencing products and services designed for synthetic biology research and industrial applications. The company provides oligonucleotide synthesis, long-fragment gene synthesis, Sanger and NGS sequencing, chemical raw materials, biological reagents, and synthetic instruments, enabling pharmaceutical, agricultural, food, and environmental sectors with efficient, high-quality, and customizable genetic solutions powered by AI and automation.
Contact Information
Website
www.tsingke.com.cnCorporate Office
- West Half Unit, Building 3, No. 105, Jinghai Third Road
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Corporate Office
- West Half Unit, Building 3, No. 105, Jinghai Third Road
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Tsingke Biotech Timeline
Tsingke Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. IPO | 26-Jun-2026 | Announced | Profitable | |||
| 8. IPO | 12-Jan-2026 | Completed | Profitable | |||
| 7. Secondary Transaction - Private | 31-Aug-2025 | Completed | Profitable | |||
| 6. Secondary Transaction - Private | 19-Mar-2025 | Completed | Profitable | |||
| 5. Later Stage VC (Series B) | 28-Nov-2022 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 28-Nov-2022 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 06-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 20-Jan-2022 | $23.8M | $26.8M | Completed | Generating Revenue | |
| 1. Early Stage VC | 06-May-2021 | $3.07M | $3.07M | Completed | Generating Revenue |
Tsingke Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,200,000 | $2.32 | $2.32 | 1x | $2.32 | 1.65% |
Tsingke Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tsingke Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tsingke Biotech Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing Xietong Shifu Asset Management | Venture Capital | Minority | ||
| Fortune Capital | Venture Capital | Minority | ||
| Gandao Investment Holding Company | Asset Manager | Minority | ||
| Henan Investment Group | Growth/Expansion | Minority | ||
| Jolmo Investment | Venture Capital | Minority |
Tsingke Biotech Investments (1)
Tsingke Biotech’s most recent deal was a Early Stage VC with Zhongyuan Yuze for . The deal was made on 06-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zhongyuan Yuze | 06-Jan-2026 | Early Stage VC | Biotechnology |
Tsingke Biotech FAQs
-
When was Tsingke Biotech founded?
Tsingke Biotech was founded in 2017.
-
Where is Tsingke Biotech headquartered?
Tsingke Biotech is headquartered in Beijing, China.
-
What is the size of Tsingke Biotech?
Tsingke Biotech has 1,252 total employees.
-
What industry is Tsingke Biotech in?
Tsingke Biotech’s primary industry is Discovery Tools (Healthcare).
-
Is Tsingke Biotech a private or public company?
Tsingke Biotech is a Private company.
-
What is Tsingke Biotech’s current revenue?
The current revenue for Tsingke Biotech is .
-
How much funding has Tsingke Biotech raised over time?
Tsingke Biotech has raised $82.5M.
-
Who are Tsingke Biotech’s investors?
Beijing Xietong Shifu Asset Management, Fortune Capital, Gandao Investment Holding Company, Henan Investment Group, and Jolmo Investment are 5 of 14 investors who have invested in Tsingke Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
